Annual Long Term Debt
$60.50 B
+$28.57 B+89.50%
31 December 2023
Summary:
Pfizer annual long term debt is currently $60.50 billion, with the most recent change of +$28.57 billion (+89.50%) on 31 December 2023. During the last 3 years, it has risen by +$24.93 billion (+70.08%). PFE annual long term debt is now at all-time high.PFE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$56.92 B
+$185.00 M+0.33%
30 September 2024
Summary:
Pfizer quarterly long term debt is currently $56.92 billion, with the most recent change of +$185.00 million (+0.33%) on 30 September 2024. Over the past year, it has dropped by -$4.13 billion (-6.77%). PFE quarterly long term debt is now -7.23% below its all-time high of $61.36 billion, reached on 01 June 2023.PFE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +89.5% | -6.8% |
| 3 y3 years | +70.1% | +63.7% |
| 5 y5 years | +83.8% | +57.9% |
PFE Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +89.5% | -7.2% | +85.2% |
| 5 y | 5 years | at high | +89.5% | -7.2% | +85.2% |
| alltime | all time | at high | >+9999.0% | -7.2% | >+9999.0% |
Pfizer Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.92 B(+0.3%) |
| June 2024 | - | $56.73 B(-6.2%) |
| Mar 2024 | - | $60.48 B(-0.0%) |
| Dec 2023 | $60.50 B(+89.5%) | $60.50 B(-0.9%) |
| Sept 2023 | - | $61.05 B(-0.5%) |
| June 2023 | - | $61.36 B(+99.6%) |
| Mar 2023 | - | $30.74 B(-3.7%) |
| Dec 2022 | $31.93 B(-8.1%) | $31.93 B(+0.9%) |
| Sept 2022 | - | $31.65 B(-4.6%) |
| June 2022 | - | $33.17 B(-3.6%) |
| Mar 2022 | - | $34.42 B(-1.0%) |
| Dec 2021 | $34.76 B(-2.3%) | $34.76 B(-0.1%) |
| Sept 2021 | - | $34.78 B(+2.8%) |
| June 2021 | - | $33.85 B(+0.0%) |
| Mar 2021 | - | $33.84 B(-4.9%) |
| Dec 2020 | $35.57 B(+2.7%) | $35.57 B(-26.1%) |
| Sept 2020 | - | $48.16 B(-4.7%) |
| June 2020 | - | $50.53 B(+39.3%) |
| Mar 2020 | - | $36.28 B(+4.7%) |
| Dec 2019 | $34.65 B(+5.3%) | $34.65 B(-3.9%) |
| Sept 2019 | - | $36.04 B(-0.3%) |
| June 2019 | - | $36.17 B(+1.2%) |
| Mar 2019 | - | $35.73 B(+8.6%) |
| Dec 2018 | $32.91 B(+0.7%) | $32.91 B(-2.2%) |
| Sept 2018 | - | $33.65 B(+16.3%) |
| June 2018 | - | $28.93 B(-9.1%) |
| Mar 2018 | - | $31.83 B(-2.6%) |
| Dec 2017 | $32.67 B(+7.5%) | $32.67 B(-5.3%) |
| Sept 2017 | - | $34.50 B(+0.9%) |
| June 2017 | - | $34.19 B(-5.9%) |
| Mar 2017 | - | $36.33 B(+19.5%) |
| Dec 2016 | $30.40 B(+5.8%) | $30.40 B(-0.1%) |
| Sept 2016 | - | $30.44 B(-0.1%) |
| June 2016 | - | $30.46 B(+9.5%) |
| Mar 2016 | - | $27.82 B(-3.2%) |
| Dec 2015 | $28.74 B(-8.9%) | $28.74 B(-1.2%) |
| Sept 2015 | - | $29.08 B(+8.8%) |
| June 2015 | - | $26.73 B(-9.0%) |
| Mar 2015 | - | $29.37 B(-6.9%) |
| Dec 2014 | $31.54 B(+3.5%) | $31.54 B(-0.4%) |
| Sept 2014 | - | $31.67 B(-1.9%) |
| June 2014 | - | $32.27 B(+16.7%) |
| Mar 2014 | - | $27.65 B(-9.2%) |
| Dec 2013 | $30.46 B(-1.8%) | $30.46 B(-4.2%) |
| Sept 2013 | - | $31.81 B(+0.9%) |
| June 2013 | - | $31.53 B(+0.2%) |
| Mar 2013 | - | $31.48 B(+1.4%) |
| Dec 2012 | $31.04 B(-11.1%) | $31.04 B(-0.2%) |
| Sept 2012 | - | $31.08 B(+0.7%) |
| June 2012 | - | $30.87 B(-8.0%) |
| Mar 2012 | - | $33.54 B(-4.0%) |
| Dec 2011 | $34.93 B(-9.1%) | $34.93 B(-1.3%) |
| Sept 2011 | - | $35.40 B(-0.9%) |
| June 2011 | - | $35.72 B(+1.2%) |
| Mar 2011 | - | $35.31 B(-8.1%) |
| Dec 2010 | $38.41 B(-11.1%) | $38.41 B(-1.5%) |
| Sept 2010 | - | $39.01 B(+3.3%) |
| June 2010 | - | $37.77 B(-1.3%) |
| Mar 2010 | - | $38.28 B(-11.4%) |
| Dec 2009 | $43.19 B(+442.4%) | $43.19 B(+10.1%) |
| Sept 2009 | - | $39.24 B(+0.9%) |
| June 2009 | - | $38.89 B(+39.7%) |
| Mar 2009 | - | $27.83 B(+249.5%) |
| Dec 2008 | $7.96 B(+8.9%) | $7.96 B(+11.3%) |
| Sept 2008 | - | $7.15 B(-1.3%) |
| June 2008 | - | $7.25 B(-11.0%) |
| Mar 2008 | - | $8.14 B(+11.3%) |
| Dec 2007 | $7.31 B(+31.9%) | $7.31 B(+21.1%) |
| Sept 2007 | - | $6.04 B(+4.6%) |
| June 2007 | - | $5.78 B(+21.1%) |
| Mar 2007 | - | $4.77 B(-14.0%) |
| Dec 2006 | $5.55 B | $5.55 B(-0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $5.56 B(+2.0%) |
| June 2006 | - | $5.45 B(-16.3%) |
| Mar 2006 | - | $6.51 B(+2.5%) |
| Dec 2005 | $6.35 B(-12.8%) | $6.35 B(+17.2%) |
| Sept 2005 | - | $5.41 B(-1.9%) |
| June 2005 | - | $5.52 B(-14.2%) |
| Mar 2005 | - | $6.43 B(-11.6%) |
| Dec 2004 | $7.28 B(+26.5%) | $7.28 B(-8.5%) |
| Sept 2004 | - | $7.96 B(+17.6%) |
| June 2004 | - | $6.76 B(-5.3%) |
| Mar 2004 | - | $7.14 B(+24.1%) |
| Dec 2003 | $5.75 B(+83.3%) | $5.75 B(-10.6%) |
| Sept 2003 | - | $6.44 B(-4.0%) |
| June 2003 | - | $6.71 B(+80.7%) |
| Mar 2003 | - | $3.71 B(+18.2%) |
| Dec 2002 | $3.14 B(+20.4%) | $3.14 B(+0.7%) |
| Sept 2002 | - | $3.12 B(+1.5%) |
| June 2002 | - | $3.07 B(+19.1%) |
| Mar 2002 | - | $2.58 B(-1.1%) |
| Dec 2001 | $2.61 B(+132.3%) | $2.61 B(+25.0%) |
| Sept 2001 | - | $2.09 B(-11.8%) |
| June 2001 | - | $2.37 B(+25.4%) |
| Mar 2001 | - | $1.89 B(+68.1%) |
| Dec 2000 | $1.12 B(-36.7%) | $1.12 B(-10.7%) |
| Sept 2000 | - | $1.26 B(-0.7%) |
| June 2000 | - | $1.27 B(+141.6%) |
| Mar 2000 | - | $524.00 M(-70.5%) |
| Dec 1999 | $1.77 B(+236.6%) | $1.77 B(+237.9%) |
| Sept 1999 | - | $525.00 M(-0.9%) |
| June 1999 | - | $530.00 M(+1.0%) |
| Mar 1999 | - | $525.00 M(-0.4%) |
| Dec 1998 | $527.00 M(-27.3%) | $527.00 M(-0.2%) |
| Sept 1998 | - | $528.00 M(-27.1%) |
| June 1998 | - | $724.00 M(-0.7%) |
| Mar 1998 | - | $729.00 M(+0.6%) |
| Dec 1997 | $725.00 M(+5.5%) | $725.00 M(-0.5%) |
| Sept 1997 | - | $729.00 M(-0.3%) |
| June 1997 | - | $731.00 M(-0.1%) |
| Mar 1997 | - | $732.00 M(+6.6%) |
| Dec 1996 | $687.00 M(-17.5%) | $687.00 M(+24.2%) |
| Sept 1996 | - | $553.00 M(-5.1%) |
| June 1996 | - | $583.00 M(-0.2%) |
| Mar 1996 | - | $584.00 M(-29.9%) |
| Dec 1995 | $833.00 M(+37.9%) | $833.00 M(+132.6%) |
| Sept 1995 | - | $358.20 M(-41.4%) |
| June 1995 | - | $611.20 M(+0.2%) |
| Mar 1995 | - | $609.90 M(+0.9%) |
| Dec 1994 | $604.20 M(+5.9%) | $604.20 M(+3.1%) |
| Sept 1994 | - | $586.30 M(+2.8%) |
| June 1994 | - | $570.20 M(+0.0%) |
| Mar 1994 | - | $570.10 M(-0.1%) |
| Dec 1993 | $570.50 M(-0.1%) | $570.50 M(-0.4%) |
| Sept 1993 | - | $572.90 M(-0.3%) |
| June 1993 | - | $574.40 M(+0.1%) |
| Mar 1993 | - | $573.60 M(+0.4%) |
| Dec 1992 | $571.30 M(+44.0%) | $571.30 M(-3.4%) |
| Sept 1992 | - | $591.60 M(+1.8%) |
| June 1992 | - | $581.00 M(+0.2%) |
| Mar 1992 | - | $579.80 M(+46.2%) |
| Dec 1991 | $396.60 M(+105.2%) | $396.60 M(+166.4%) |
| Sept 1991 | - | $148.90 M(-5.3%) |
| June 1991 | - | $157.20 M(-11.3%) |
| Mar 1991 | - | $177.20 M(-8.3%) |
| Dec 1990 | $193.30 M(+1.4%) | $193.30 M(+1.8%) |
| Sept 1990 | - | $189.90 M(+4.5%) |
| June 1990 | - | $181.80 M(-4.1%) |
| Mar 1990 | - | $189.60 M(-0.5%) |
| Dec 1989 | $190.60 M(-16.0%) | $190.60 M(-16.0%) |
| Dec 1988 | $226.90 M(-8.8%) | $226.90 M(-8.8%) |
| Dec 1987 | $248.90 M(-12.8%) | $248.90 M(-12.8%) |
| Dec 1986 | $285.40 M(-11.8%) | $285.40 M(-11.8%) |
| Dec 1985 | $323.50 M(-4.4%) | $323.50 M(-4.4%) |
| Dec 1984 | $338.30 M | $338.30 M |
FAQ
- What is Pfizer annual long term debt?
- What is the all time high annual long term debt for Pfizer?
- What is Pfizer annual long term debt year-on-year change?
- What is Pfizer quarterly long term debt?
- What is the all time high quarterly long term debt for Pfizer?
- What is Pfizer quarterly long term debt year-on-year change?
What is Pfizer annual long term debt?
The current annual long term debt of PFE is $60.50 B
What is the all time high annual long term debt for Pfizer?
Pfizer all-time high annual long term debt is $60.50 B
What is Pfizer annual long term debt year-on-year change?
Over the past year, PFE annual long term debt has changed by +$28.57 B (+89.50%)
What is Pfizer quarterly long term debt?
The current quarterly long term debt of PFE is $56.92 B
What is the all time high quarterly long term debt for Pfizer?
Pfizer all-time high quarterly long term debt is $61.36 B
What is Pfizer quarterly long term debt year-on-year change?
Over the past year, PFE quarterly long term debt has changed by -$4.13 B (-6.77%)